No abstract available
MeSH terms
-
Cost-Benefit Analysis
-
Drug Therapy, Combination
-
Humans
-
Malignant Carcinoid Syndrome / drug therapy*
-
Octreotide / therapeutic use
-
Precision Medicine
-
Radiopharmaceuticals / therapeutic use
-
Somatostatin / analogs & derivatives*
-
Somatostatin / economics
-
Time Factors
Substances
-
Radiopharmaceuticals
-
Somatostatin
-
Octreotide